Skip to content

Drug interactions

Deutetrabenazine + Sunitinib

Severity: Minor

Deutetrabenazine and Sunitinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sunitinib can prolong the QT interval, while deutetrabenazine has little QT effect at recommended doses. Risk is small but may increase in patients with bradycardia, electrolyte disturbances or other QT-prolonging drugs.

What this interaction means in plain words

Deutetrabenazine and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Deutetrabenazine belongs to Central Nervous System; Sunitinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible additive QT prolongation, although deutetrabenazine's own effect is small at recommended doses.

What to do

Check baseline ECG and electrolytes in patients with additional QT risk factors. Correct potassium and magnesium abnormalities.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deutetrabenazine and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deutetrabenazine with Sunitinib?

MediHelp rates the interaction as minor. Deutetrabenazine and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sunitinib can prolong the QT interval, while deutetrabenazine has little QT effect at recommended doses. Risk is small but may increase in patients with bradycardia, electrolyte disturbances or other QT-prolonging drugs.

How serious is the interaction between Deutetrabenazine and Sunitinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG and electrolytes in patients with additional QT risk factors. Correct potassium and magnesium abnormalities.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in